Trademark: 90770788
Word
PHAIM AIM ANTIGENIC IMMUNE MODULATION
Status Date
Tuesday, September 13, 2022
Registration Number
6842815
Registration Date
Tuesday, September 13, 2022
Filing Date
Saturday, June 12, 2021
Published for Opposition
Tuesday, June 28, 2022
5 Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations; Chemical preparations for medical purposes
35 Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertising, marketing and promotional services; Advertising; Compilation of statistical data for use in scientific research; Compilation of statistical data relating to medical research; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases
44 Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis
10 Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposes; Diagnostic, examination, and monitoring equipment; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments; Medical diagnostic instruments; Medical testing instruments
"ANTIGENIC IMMUNE MODULATION"
Sep 13, 2022
Notice Of Registration Confirmation Emailed
Sep 13, 2022
Registered-Principal Register
Jun 28, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2022
Published For Opposition
Jun 8, 2022
Notification Of Notice Of Publication E-Mailed
May 21, 2022
Approved For Pub - Principal Register
May 15, 2022
Examiner's Amendment Entered
May 15, 2022
Notification Of Examiners Amendment E-Mailed
May 15, 2022
Examiners Amendment E-Mailed
May 15, 2022
Examiners Amendment -Written
Mar 11, 2022
Teas/Email Correspondence Entered
Mar 11, 2022
Correspondence Received In Law Office
Mar 9, 2022
Assigned To Lie
Mar 7, 2022
Teas Response To Suspension Inquiry Received
Mar 3, 2022
Notification Of Letter Of Suspension E-Mailed
Mar 3, 2022
Letter Of Suspension E-Mailed
Mar 3, 2022
Suspension Letter Written
Mar 3, 2022
Assigned To Examiner
Sep 1, 2021
New Application Office Supplied Data Entered In Tram
Jun 16, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
